Doo‐Man Oh
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Drug Solubulity and Delivery Systems 3
- Oncology 6
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Gordon L. Amidon (12 shared papers)Rane L. Curl (2 shared papers)Hyo-Kyung Han (5 shared papers)Julie K. Rhie (2 shared papers)John R. Crison (1 shared paper)Wolfgang Sadée (2 shared papers)Remco L.A. de Vrueh (1 shared paper)Philip L. Smith (1 shared paper)
- Journals
- Pharmaceutical Research (5 papers)Journal of Pharmaceutical Sciences (3 papers)Archives of Pharmacal Research (2 papers)Pharmaceutical biotechnology (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Doo‐Man Oh
14 papers receiving 921 citations
Peers
Comparison fields: 5 of 91
- Pharmaceutical Science 348
- Oncology 334
- Biochemistry 79
- Pharmacology 87
- Infectious Diseases 147
Countries citing papers authored by Doo‐Man Oh
This map shows the geographic impact of Doo‐Man Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doo‐Man Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doo‐Man Oh more than expected).
Fields of papers citing papers by Doo‐Man Oh
This network shows the impact of papers produced by Doo‐Man Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doo‐Man Oh. The network helps show where Doo‐Man Oh may publish in the future.
Co-authors
The 24 scholars most cited alongside Doo‐Man Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 272 | |
| 2 | 1993 | 209 | |
| 3 | 2000 | 134 | |
| 4 | 1998 | 90 | |
| 5 | 2003 | 66 | |
| 6 | 2002 | 48 | |
| 7 | 2003 | 43 | |
| 8 | 1999 | 35 | |
| 9 | 1991 | 31 | |
| 10 | 1995 | 25 | |
| 11 | 1999 | 20 | |
| 12 | 2002 | 4 | |
| 13 | 2005 | 2 | |
| 14 | 1994 | 1 |
About Doo‐Man Oh
Doo‐Man Oh is a scholar working on Pharmaceutical Science, Oncology, Biochemistry, Pediatrics, Perinatology and Child Health and Physiology, having authored 14 papers that have together received 980 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Drug Solubulity and Delivery Systems (3 papers), Amino Acid Enzymes and Metabolism (3 papers), Crystallization and Solubility Studies (2 papers), Surfactants and Colloidal Systems (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Glycogen Storage Diseases and Myoclonus (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Pharmaceutical Science (348 citations), Oncology (334 citations), Biochemistry (79 citations), Pharmacology (87 citations) and Infectious Diseases (147 citations). Doo‐Man Oh has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Gordon L. Amidon, Rane L. Curl, Hyo-Kyung Han, Julie K. Rhie, John R. Crison, Wolfgang Sadée, Remco L.A. de Vrueh, Philip L. Smith, David H. Fleisher and Lilian Yanqing Li. Their work appears in journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences, Archives of Pharmacal Research, Pharmaceutical biotechnology and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.